fluocinolone

(redirected from Fluocinolone acetonide)
Also found in: Medical, Wikipedia.
Related to Fluocinolone acetonide: neomycin sulphate
Translations

fluocinolone

n fluocinolona
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
YUTIQ (fluocinolone acetonide intravitreal implant) 0.18 mg for chronic non-infectious uveitis affecting the posterior segment of the eye
Jaffe, M.D., Robert Machemer Professor of Ophthalmology at Duke University School of Medicine, at the 2019 Association for Research in Vision and Ophthalmology Annual Meeting in Vancouver, British Columbia, in an oral session entitled "Treatment of Non-infectious Uveitis that Affects the Posterior Segment with a Single Intravitreal Fluocinolone Acetonide Insert - 3-year Results".
Corticosteroids administered as intravitreal implants such as dexamethasone (Ozurdex) or fluocinolone acetonide (Iluvien) have also been approved for DME.
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema.
ILUVIEN implant (non-biodegradable 0.2 ug/d fluocinolone acetonide; Alimera Sciences, Inc.) is a sustained-release intravitreal steroid lasting up to 36 months that has been approved in the UK to treat chronic refractory CMO in pseudophakic eyes unresponsive to available therapies.
09 Iluvien implants are designed to release fluocinolone acetonide into the eye over what period of time?
A randomized control trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma.
At 3 years in the FAME trials, Iluvien (0.2 [micro]g fluocinolone acetonide per day) led to 28.7% of patients achieving a [greater than or equal to] 15 letter score improvement in visual acuity versus 18.9% in the sham group.
Healthcare company Perrigo Company plc (NYSE:PRGO)(TASE:PRGO) reported on Wednesday the receipt of final approval from the US Food and Drug Administration for its AB rated Abbreviated New Drug Application referencing DermOtic Oil, 0.01% Ear Drops (fluocinolone acetonide oil 0.01%).
While increased IOP sometimes requires medical treatment, only 2% of treated eyes in a previous study needed surgical intervention to reduce IOP.43 Fluocinolone acetonide and dexamethasone implants are new options found to be efficient in various studies.44,45
Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma.